MedPath

The Efficacy and Safety of Dexibuprofen Syrup

Phase 3
Completed
Conditions
Fever
Respiratory Tract Infection
Interventions
Registration Number
NCT00812422
Lead Sponsor
Inje University
Brief Summary

The purpose of this study is to compare the safety and efficacy of dexibuprofen syrup and ibuprofen syrup in patients with fever due to common cold.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Common cold with fever
  • Age 6 months to 14 years
Exclusion Criteria
  • Gastric ulcer
  • Bleeding tendency
  • Liver disease
  • Kidney disease
  • Hypertension
  • Hypersensitivity to the drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dexibuprofen 1DexibuprofenDexibuprofen 2.5 or 5 mg/kg
Dexibuprofen 2DexibuprofenDexibuprofen 3.5 or 7 mg/kg
IbuprofenIbuprofenIbuprofen 5 or 10 mg/kg
Primary Outcome Measures
NameTimeMethod
measure reduction in fevermeasure temperature every hour for 3 hours then once again 3 days later
Secondary Outcome Measures
NameTimeMethod
determine safety of dexibuprofen by unwanted reaction, clinical laboratory test and physical examination.every hour for 3 hours (unwanted reaction). 3 days later (clinical laboratory test and physical examination).

Trial Locations

Locations (4)

Inje University Sanggye Paik Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath